Related Experiment Video

Updated: Sep 26, 2025

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

1.0K

Optimal potassium levels in patients with heart failure

Radek Pudil

    Vnitrni Lekarstvi
    |April 23, 2022
    PubMed

    Insights

    Heart failure treatments can alter potassium levels, necessitating careful monitoring. Optimal potassium levels for heart failure patients are between 4-5 mmol/L to improve outcomes.

    Area of Science:

    • Cardiology
    • Nephrology
    • Pharmacology

    Background:

    • Heart failure (HF) management involves medications that significantly impact serum potassium.
    • Diuretics tend to lower potassium, while ACE inhibitors, ARBs, sacubitubitril/valsartan, and spironolactone increase it.
    • Comorbidities affecting renal function further complicate potassium balance in HF patients.

    Purpose of the Study:

    • To review the impact of heart failure therapies on potassium levels.
    • To emphasize the clinical significance of monitoring potassium in heart failure.
    • To present evidence-based optimal potassium targets in heart failure.

    Main Methods:

    • Literature review of studies investigating potassium levels and mortality in heart failure.
    • Analysis of drug classes affecting potassium balance in heart failure.
    • Evaluation of the role of comorbidities in potassium dysregulation.

    Main Results:

    • Several drug classes used in heart failure therapy significantly influence serum potassium.
    • Both hypokalemia and hyperkalemia pose serious risks to heart failure patients.
    • Recent studies indicate an optimal serum potassium range of 4-5 mmol/L for patients with heart failure.

    Conclusions:

    • Close monitoring of serum potassium is crucial for patients with heart failure.
    • Therapeutic strategies should aim to maintain potassium levels within the 4-5 mmol/L range.
    • Optimizing potassium levels may improve prognosis and reduce mortality in heart failure.

    Keywords:
    SGLT2heart failuremortalityoptimal level of kalemiapotassium

    More Related Videos

    Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique08:11

    Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique

    Published on: November 11, 2022

    3.0K
    Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure05:16

    Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

    Published on: June 10, 2025

    242

    Related Concept Videos

    Heart Failure Drugs: Diuretics01:22

    Heart Failure Drugs: Diuretics

    Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
    515
    Heart Failure VI: Adjunct Therapies01:22

    Heart Failure VI: Adjunct Therapies

    Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
    44
    Heart Failure Drugs: Inotropic Agents01:26

    Heart Failure Drugs: Inotropic Agents

    Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
    765
    Heart Failure V: Medical Management01:30

    Heart Failure V: Medical Management

    Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
    36
    Acute Kidney Injury VI: Nursing Management01:22

    Acute Kidney Injury VI: Nursing Management

    Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
    80
    Heart Failure VII: Nursing Interventions01:30

    Heart Failure VII: Nursing Interventions

    The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
    151